Global Exosome Trials

Éditeur :

Springer

Paru le : 2026-01-01

This book offers a comprehensive review of the global exosome trials that are registered with the United States National Institutes of Health website, clinicaltrials.gov. Clinicaltrials.gov is the largest listing of research studies in the world. The study titles are provided, as is the country of o...
Voir tout
Ce livre est accessible aux handicaps Voir les informations d'accessibilité
Ebook téléchargement , DRM LCP 🛈 DRM Adobe 🛈
Compatible lecture en ligne (streaming)
116,04
Ajouter à ma liste d'envies
Téléchargement immédiat
Dès validation de votre commande
Image Louise Reader présentation

Louise Reader

Lisez ce titre sur l'application Louise Reader.

À propos


Éditeur

Collection
n.c

Parution
2026-01-01

Pages
375 pages

EAN papier
9783031964190

Auteur(s) du livre


Jeffrey N. Weiss, M.D., is the former Chief of Retinal Surgery at the Joslin Diabetes Center in Boston, Faculty of Harvard Medical School, and Visiting Scientist at the Massachusetts Institute of Technology. Dr. Weiss is the author of more than 100 publications, including 30 books, holds more than 23 U.S. and foreign patents and has been a Reviewer for multiple scholarly journals.  He has served as a Visiting Professor, performed surgery, and lectured both nationally and internationally.  Dr. Weiss is also the founder of two companies, Ocular Research Associates Inc., and Micron Ophthalmic, Inc., which have manufactured and sold Dr. Weiss’ inventions worldwide. Dr. Weiss was the first to invent the equipment and develop the technique to safely perform retinal vessel cannulation. This surgery remains the only option for patients with severe stroke in the eye. He was also the first to report the use of hyperbaric oxygen treatment to successfully treat dry age-related macular degeneration and longer standing central retinal artery occlusions. Dr. Weiss performed the first retinal stem cell surgery in 2010, and is the Principal Investigator of The Stem Cell Ophthalmology Treatment Studies I/II, the largest retinal and optic nerve stem cell studies in the world, and The Neurologic Stem Cell Treatment Study. The studies are Institutional Review Board (IRB) approved, registered with NIH, and listed on ClinicalTrials.gov

Caractéristiques détaillées - droits

EAN PDF
9783031964206
Prix
116,04 €
Nombre pages copiables
3
Nombre pages imprimables
37
Taille du fichier
10322 Ko
EAN EPUB
9783031964206
Prix
116,04 €
Nombre pages copiables
3
Nombre pages imprimables
37
Taille du fichier
399 Ko

Suggestions personnalisées